Patents by Inventor James Berenson

James Berenson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITIONS AND METHODS FOR TREATMENT OF DRUG RESISTANT MULTIPLE MYELOMA
    Publication number: 20150299333
    Abstract: This invention relates to a novel target for production of immune and non-immune based therapeutics and for disease diagnosis. More particularly, the invention provides therapeutic antibodies against TMEM154 antigens, which are differentially expressed in cancer, and diagnostic and therapeutic usages, wherein the cancer is relates to multiple myeloma, including multiple myeloma precursor diseases. This invention further relates to extracellular domains of TMEM154 proteins and variants, and therapeutic usages thereof.
    Type: Application
    Filed: February 27, 2015
    Publication date: October 22, 2015
    Applicant: COMPUGEN LTD.
    Inventors: Gad S. COJOCARU, Haiming CHEN, James BERENSON
  • Compositions and methods for treatment of drug resistant multiple myeloma
    Patent number: 8999335
    Abstract: This invention relates to a novel target for production of immune and non-immune based therapeutics and for disease diagnosis. More particularly, the invention provides therapeutic antibodies against TMEM154 antigens, which are differentially expressed in cancer, and diagnostic and therapeutic usages, wherein the cancer is relates to multiple myeloma, including multiple myeloma precursor diseases. This invention further relates to extracellular domains of TMEM154 proteins and variants, and therapeutic usages thereof.
    Type: Grant
    Filed: September 16, 2011
    Date of Patent: April 7, 2015
    Assignee: Compugen Ltd.
    Inventors: Gad S. Cojocaru, Haiming Chen, James Berenson
  • COMPOSITIONS AND METHODS FOR TREATMENT OF DRUG RESISTANT MULTIPLE MYELOMA
    Publication number: 20130266510
    Abstract: This invention relates to a novel target for production of immune and non-immune based therapeutics and for disease diagnosis. More particularly, the invention provides therapeutic antibodies against TMEM154 antigens, which are differentially expressed in cancer, and diagnostic and therapeutic usages, wherein the cancer is relates to multiple myeloma, including multiple myeloma precursor diseases. This invention further relates to extracellular domains of TMEM154 proteins and variants, and therapeutic usages thereof.
    Type: Application
    Filed: September 16, 2011
    Publication date: October 10, 2013
    Applicant: Compugen Ltd.
    Inventors: Gad S. Cojocaru, Haiming Chen, James Berenson